Reiner Schaumann

1.5k total citations
54 papers, 1.1k citations indexed

About

Reiner Schaumann is a scholar working on Clinical Biochemistry, Infectious Diseases and Epidemiology. According to data from OpenAlex, Reiner Schaumann has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Clinical Biochemistry, 13 papers in Infectious Diseases and 13 papers in Epidemiology. Recurrent topics in Reiner Schaumann's work include Bacterial Identification and Susceptibility Testing (21 papers), Antibiotic Resistance in Bacteria (13 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Reiner Schaumann is often cited by papers focused on Bacterial Identification and Susceptibility Testing (21 papers), Antibiotic Resistance in Bacteria (13 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Reiner Schaumann collaborates with scholars based in Germany, Austria and United Kingdom. Reiner Schaumann's co-authors include Arne C. Rodloff, G Ackermann, Catalina-Suzana Stîngu, Klaus Eschrich, Holger Jentsch, Daniela Koch, Marina C. Claros, Ellie J. C. Goldstein, Monika Krüger and Helge Böhnel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Reiner Schaumann

54 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reiner Schaumann Germany 20 337 319 314 207 191 54 1.1k
Joseph R. DiPersio United States 18 273 0.8× 520 1.6× 357 1.1× 301 1.5× 180 0.9× 37 1.1k
Armine Sefton United Kingdom 18 108 0.3× 250 0.8× 382 1.2× 131 0.6× 175 0.9× 40 976
Jette Jung Germany 12 485 1.4× 142 0.4× 299 1.0× 114 0.6× 241 1.3× 21 1.0k
Carl‐Erik Nord Sweden 22 193 0.6× 231 0.7× 275 0.9× 203 1.0× 145 0.8× 47 1.1k
V.O. Rotimi Kuwait 17 134 0.4× 269 0.8× 155 0.5× 136 0.7× 222 1.2× 41 1.0k
Matthias Marschal Germany 16 291 0.9× 270 0.8× 294 0.9× 97 0.5× 529 2.8× 31 1.4k
G. Młynarczyk Poland 21 251 0.7× 502 1.6× 469 1.5× 144 0.7× 290 1.5× 176 1.4k
Ingrid Wybo Belgium 23 649 1.9× 311 1.0× 392 1.2× 338 1.6× 280 1.5× 67 1.4k
Bianca Graves Australia 8 220 0.7× 373 1.2× 345 1.1× 93 0.4× 231 1.2× 12 1.2k
S K Spangler United States 24 387 1.1× 443 1.4× 589 1.9× 281 1.4× 150 0.8× 49 1.4k

Countries citing papers authored by Reiner Schaumann

Since Specialization
Citations

This map shows the geographic impact of Reiner Schaumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reiner Schaumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reiner Schaumann more than expected).

Fields of papers citing papers by Reiner Schaumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reiner Schaumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reiner Schaumann. The network helps show where Reiner Schaumann may publish in the future.

Co-authorship network of co-authors of Reiner Schaumann

This figure shows the co-authorship network connecting the top 25 collaborators of Reiner Schaumann. A scholar is included among the top collaborators of Reiner Schaumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reiner Schaumann. Reiner Schaumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Labischinski, Harald, et al.. (2014). Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria. International Journal of Antimicrobial Agents. 44(5). 420–423. 14 indexed citations
2.
Ruscher, Claudia, et al.. (2014). Inguinal skin colonization with multidrug-resistant bacteria among residents of elderly care facilities: Frequency, persistence, molecular analysis and clinical impact. International Journal of Medical Microbiology. 304(8). 1123–1134. 19 indexed citations
3.
Schnell, Sylvia, et al.. (2014). The importance of growth kinetic analysis in determining bacterial susceptibility against antibiotics and silver nanoparticles. Frontiers in Microbiology. 5. 544–544. 77 indexed citations
4.
Stîngu, Catalina-Suzana, Arne C. Rodloff, Holger Jentsch, Reiner Schaumann, & Klaus Eschrich. (2008). Rapid identification of oral anaerobic bacteria cultivated from subgingival biofilm by MALDI‐TOF‐MS. Oral Microbiology and Immunology. 23(5). 372–376. 60 indexed citations
5.
Rüssmann, Holger, et al.. (2007). Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens. European Journal of Clinical Microbiology & Infectious Diseases. 26(2). 115–119. 25 indexed citations
6.
7.
8.
Ackermann, G, Yajarayma Tang-Feldman, Reiner Schaumann, et al.. (2003). Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile. Clinical Microbiology and Infection. 9(6). 526–530. 39 indexed citations
9.
Schaumann, Reiner, Wolfram Pönisch, Jörg Helbig, et al.. (2001). Pericarditis after Allogeneic Peripheral Blood Stem Cell Transplantation Caused by Legionella pneumophila (Non-serogroup 1). Infection. 29(1). 51–53. 6 indexed citations
10.
Ackermann, G, et al.. (2001). Rapidly Growing Tumor-Like Brain Lesion. Infection. 29(5). 278–279. 5 indexed citations
11.
Schaumann, Reiner, Kathy Stein, C. Eckhardt, G Ackermann, & Arne C. Rodloff. (2001). Infections Caused by Stenotrophomonas maltophilia - A Prospective Study. Infection. 29(4). 205–208. 31 indexed citations
12.
Schaumann, Reiner, et al.. (2000). In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria. International Journal of Antimicrobial Agents. 16(3). 225–232. 20 indexed citations
13.
Ackermann, G, et al.. (2000). Comparative Activity of Moxifloxacin in Vitro Against Obligately Anaerobic Bacteria. European Journal of Clinical Microbiology & Infectious Diseases. 19(3). 228–232. 55 indexed citations
14.
Ackermann, G, et al.. (2000). Chronic Factitious Illness Presenting as Munchausen's Gonarthritis. European Journal of Clinical Microbiology & Infectious Diseases. 19(1). 70–71. 1 indexed citations
15.
Schaumann, Reiner, et al.. (1999). Facial Palsy Caused by Borrelia Infection in a Twin Pregnancy in an Area of Nonendemicity. Clinical Infectious Diseases. 29(4). 955–956. 8 indexed citations
16.
Armbruster, Christine, et al.. (1999). Endothelial cell compatibility of clindamycin, gentamicin, ceftriaxone and teicoplanin in Bier's arterial arrest. Journal of Antimicrobial Chemotherapy. 44(2). 275–277. 3 indexed citations
17.
Schaumann, Reiner, et al.. (1999). In Vitro Activities of Gatifloxacin, Two Other Quinolones, and Five Nonquinolone Antimicrobials against Obligately Anaerobic Bacteria. Antimicrobial Agents and Chemotherapy. 43(11). 2783–2786. 23 indexed citations
18.
Weigel, Guenter, et al.. (1998). Endothelial cell compatibility of clarithromycin for intravenous use. Clinical Biochemistry. 31(8). 653–656. 11 indexed citations
19.
Schaumann, Reiner, et al.. (1997). Is TNF-α a prognostic factor in patients with sepsis?. Clinical Microbiology and Infection. 3(1). 24–31. 3 indexed citations
20.
Shah, P. M., Angelika Böhme, Reiner Schaumann, et al.. (1996). Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients. Infection. 24(6). 480–484. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph R. DiPersio Breakdown of academic impact, for papers by Armine Sefton Breakdown of academic impact, for papers by Jette Jung Breakdown of academic impact, for papers by Carl‐Erik Nord Breakdown of academic impact, for papers by V.O. Rotimi Breakdown of academic impact, for papers by Matthias Marschal Breakdown of academic impact, for papers by G. Młynarczyk Breakdown of academic impact, for papers by Ingrid Wybo Breakdown of academic impact, for papers by Bianca Graves Breakdown of academic impact, for papers by S K Spangler
Rankless by CCL
2026